Cypress Semiconductor Corp. (NASDAQ: CY) today announced its
second-quarter 2013 results, which included the remarks below from its
president and CEO, T.J. Rodgers. Highlights for the quarter included:
•
|
|
Revenue, gross margin, and earnings exceeded guidance
|
•
|
|
Cash from operations totaled $30.4 million, or 15.7% of revenue
|
•
|
|
Design wins remain strong both at strategic accounts and in
distribution
|
•
|
|
Revenue growth and earnings leverage to continue in the third quarter
|
|
|
|
Fellow shareholders:
Our revenue and earnings for the quarter are given below, compared with
those of the prior quarter and prior year:
(In thousands, except per-share data)
|
|
|
|
|
|
|
NON-GAAP
|
|
GAAP
|
|
|
Q2 2013
|
|
Q1 2013
|
|
Q2 2012
|
|
Q2 2013
|
|
Q1 2013
|
|
Q2 2012
|
Revenue
|
|
$193,466
|
|
$172,728
|
|
$201,300
|
|
$193,466
|
|
$172,728
|
|
$201,300
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross margin
|
|
53.1%
|
|
50.7%
|
|
57.0%
|
|
47.3%
|
|
45.8%
|
|
53.0%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pretax margin
|
|
11.5%
|
|
2.5%
|
|
15.3%
|
|
-3.1%
|
|
-16.6%
|
|
2.6%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss)
|
|
$21,635
|
|
$4,579
|
|
$30,298
|
|
$3,766
|
|
$(28,195)
|
|
$4,977
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted EPS
(loss per share)
|
|
$0.14
|
|
$0.03
|
|
$0.18
|
|
$0.02
|
|
$(0.19)
|
|
$0.03
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cypress performed well in the second quarter, posting revenue of $193.5
million—up 12.0% from the first quarter, exceeding our guidance. Our
revenue growth was driven by broad strength across all business units,
combined with particularly strong performance by our TrueTouch®
BU.
Our gross margins increased from 50.7% to 53.1% in the second quarter.
Non-GAAP EPS was $0.14, 4.7x the first quarter, as higher revenue and
gross margins combined with structural operating expense reductions
generated significant revenue fall-through.
I am pleased to announce that we achieved first revenue on our new PSoC®
4 product just 90 days after its launch—making PSoC 4 the fastest
overall new product ramp in Cypress’s history. We have also shipped more
than 5,000 PSoC 4 development kits, a strong leading indicator of future
demand.
We ended the second quarter with a book-to-bill of 1.05 despite having
our lowest lead times in five years. We thus expect our revenue to grow
again sequentially in the third quarter and with continued strong
earnings leverage.
Finally, I am proud to announce that our products won four awards last
quarter. Embedded Computing Design magazine named PSoC 4 an
“Editor’s Choice Product” in May, and our fourth-generation touchscreen
chip, Gen4, won in June. PSoC 4 also won the 19th annual
“Product of the Year” award given by Japan’s Semiconductor Industry
News. Finally, Cypress subsidiary AgigA Tech received a gold medal
for its nonvolatile memory systems in the renowned Edison Awards.
BUSINESS REVIEW
+ Our non-GAAP consolidated gross margin for the second quarter was
53.1%, up 2.4 percentage points from the previous quarter, due mainly to
improvement in factory utilization and product and customer mix. Our
second-quarter GAAP consolidated gross margin was 47.3%.
+ Net inventory at the end of the second quarter was $98.6 million, down
$10.6 million, or 9.7% from the first quarter, driven down by an active
corporate initiative. This figure includes $27.3 million of inventory
acquired from Ramtron.
+ Cash and investments for the second quarter totaled $102.0 million,
flat from the prior quarter. During the quarter we used $16.1 million to
pay our regular quarterly dividend and $9.7 million to pay down debt.
|
NET SALES SUMMARY
|
(In thousands, except percentages)
|
(Unaudited)
|
|
|
|
|
|
|
THREE MONTHS ENDED
|
|
|
|
June 30,
|
|
March 31,
|
|
July 1,
|
|
Sequential
|
|
Year-over-
|
Business Unit
|
|
2013
|
|
2013
|
|
2012
|
|
Change
|
|
Year Change
|
PSD1 |
|
$81,320
|
|
$65,505
|
|
$93,248
|
|
24%
|
|
-13%
|
MPD1 |
|
$88,127
|
|
$82,229
|
|
$82,949
|
|
7%
|
|
6%
|
DCD1 |
|
$21,296
|
|
$22,747
|
|
$23,273
|
|
-6%
|
|
-8%
|
ETD1, 2 |
|
$2,723
|
|
$2,247
|
|
$1,830
|
|
21%
|
|
49%
|
Total
|
|
$193,466
|
|
$172,728
|
|
$201,300
|
|
12%
|
|
-4%
|
|
|
|
|
|
|
|
|
|
|
|
Geographic
|
|
|
|
|
|
|
|
|
|
|
China and ROW
|
|
69%
|
|
64%
|
|
65%
|
|
5%
|
|
4%
|
Americas
|
|
13%
|
|
17%
|
|
17%
|
|
-4%
|
|
-4%
|
Europe
|
|
10%
|
|
11%
|
|
9%
|
|
-1%
|
|
1%
|
Japan
|
|
8%
|
|
8%
|
|
9%
|
|
0%
|
|
-1%
|
Total
|
|
100%
|
|
100%
|
|
100%
|
|
0%
|
|
0%
|
|
|
|
|
|
|
|
|
|
|
|
Channel
|
|
|
|
|
|
|
|
|
|
|
Distribution
|
|
75%
|
|
74%
|
|
76%
|
|
1%
|
|
-1%
|
Direct
|
|
25%
|
|
26%
|
|
24%
|
|
-1%
|
|
1%
|
Total
|
|
100%
|
|
100%
|
|
100%
|
|
0%
|
|
0%
|
|
1.
|
|
PSD, Programmable Systems Division; DCD, Data Communications
Division; MPD, Memory Products Division: ETD, Emerging Technology
Division.
|
2.
|
|
“Emerging Technology” includes businesses outside our core
semiconductor businesses outlined in Footnote 1. Includes
subsidiaries AgigA Tech Inc., Deca Technologies Inc., and our
foundry business unit.
|
|
|
|
SECOND-QUARTER 2013 HIGHLIGHTS
+ Cypress introduced the first two product families based on its PSoC 4
programmable system-on-chip architecture: the PSoC 4100 and PSoC 4200
families. The new families provide an entire mixed-signal embedded
system chip with a 32-bit ARM® Cortex™-M0 core for prices as
low as $1. The PSoC 4100 family, the lowest-cost ARM-based PSoC, brings
PSoC flexibility and integration to cost-sensitive, high-volume
applications. The PSoC 4200 family features a faster processor, a
36-button CapSense block, four programmable logic blocks to create
custom digital functions, programmable analog blocks for variable-gain
amplifiers and configurable filters, programmable serial interfaces,
programmable input/output pins, and multiple programmable timers,
counters and waveform generators—all on a chip one-tenth the size of an
average little fingernail.
+ Cypress’s new PSoC 3 MFi Digital Audio Development Kit helps the
designers of MFi (Made for iPod | iPhone | iPad) mobile devices and
accessories to accelerate designs that use Apple’s new, all-digital
Lightning connector. PSoC-based digital audio solutions ensure
bit-perfect audio streaming with no added or dropped audio samples. PSoC
is the de facto standard for digital audio in the music industry,
providing Cypress with a strong position in the fast-growing, $7 billion
MFi accessory market.
+ Cypress released four new PSoC Components™ for PSoC Creator™ 2.2, the
Integrated Design Environment (IDE) that supports PSoC products. PSoC
Components are production-ready “virtual chips” that replace and
integrate multiple competitor chips onto a single PSoC to create highly
customized single-chip system solutions for a broad array of
applications, from the Tesla automotive dashboard to smart residential
power meters to cell phone touchscreens.
+ Customer demand for Cypress’s new TrueTouch Gen5 touchscreen
controllers has exceeded expectations, in part due to its
industry-leading noise immunity. Noise from cell phone chargers can
render mobile phones inoperable during charging. Gen5 offers a 3x
improvement in noise immunity versus Gen4, which itself offered
best-in-class performance.
+ Cypress introduced new features in its TrueTouch Gen4 capacitive
touchscreen controller family, including the industry’s best tracking of
gloved fingers. The Gen4 solution automatically switches into glove-mode
based on the touch of a gloved finger, as compared with competitive
solutions that require users to remove their gloves and change their
smartphones’ settings in order to enable gloved touches. The family also
delivers passive stylus support to capture handwriting and signatures
accurately, and proximity detection that can eliminate false touches
such as those caused by a user’s face when making a call on a mobile
phone.
+ Cypress expanded its market-leading USB product portfolio with a
USB-Serial bridge controller family. The family is the industry’s first
to provide CapSense® capacitive touch-sensing functionality
along with two serial channels with configurable UART/SPI/I2C
communication capability. The family is also the first to integrate
efficient battery-charge detection compliant with Version 1.2 of the USB
Implementers Forum (USB-IF) battery charging specification.
+ Cypress qualified a Bluetooth® Low Energy radio on its S8™
130-nanometer flash-based SONOS process technology to combine with its
PSoC, CapSense and TrueTouch technologies, allowing the company to move
forward with single-chip solutions for emerging Bluetooth Smart
applications such as PC peripherals, sporting goods and fitness devices,
healthcare equipment and smart remote controls.
+ Cypress announced that its Board of Directors approved a quarterly
cash dividend of $0.11 per share, payable to holders of record of the
company’s common stock as of the close of business on June 27, 2013.
This dividend will be paid on July 18, 2013.
ABOUT CYPRESS
Cypress delivers high-performance, mixed-signal, programmable solutions
that provide customers with rapid time-to-market and exceptional system
value. Cypress offerings include the flagship PSoC 1, PSoC 3, PSoC 4,
and PSoC 5 programmable system-on-chip families. Cypress is a world
leader in capacitive user interface solutions including CapSense touch
sensing, TrueTouch touchscreens, and trackpad solutions for notebook PCs
and peripherals. Cypress is the world leader in USB controllers, which
enhance connectivity and performance in a wide range of consumer and
industrial products. Cypress is also the world leader in SRAM and
nonvolatile RAM memories. Cypress serves numerous major markets,
including consumer, mobile handsets, computation, data communications,
automotive, industrial, and military. Cypress trades on the NASDAQ
Global Select Market under the ticker symbol CY. Visit Cypress online at www.cypress.com.
FORWARD-LOOKING STATEMENTS
Statements herein that are not historical facts and that refer to
Cypress or its subsidiaries’ plans and expectations for Q3 2013 and the
remainder of fiscal year 2013 and beyond are forward-looking statements
made pursuant to the Private Securities Litigation Reform Act of 1995.
We may use words such as “believe,” “expect,” “future,” “plan,” “intend”
and similar expressions to identify such forward-looking statements that
include, but are not limited to, statements related to the semiconductor
market, the strength and growth of our proprietary and programmable
products, our expectations regarding our Q3 2013 revenue and earnings
leverage, margins, profit, cash flow and cost-saving measures; and our
expectations regarding the demand for our products and how our products
are expected to perform, as well as our future design win activity and
market share gains. Such statements reflect our current expectations,
which are based on information and data available to our management as
of the date of this release. Our actual results may differ materially
due to a variety of uncertainties and risk factors, including, but not
limited to, the state of and future of the global economy, business
conditions and growth trends in the semiconductor market, whether our
products perform as expected, whether the demand for our proprietary and
programmable products is fully realized, whether our product and design
wins and kit sales result in increased sales, our ability to manage our
business to have strong earnings, reduce operating expenses, factory
utilization, the strength or softness of the markets we serve, our
ability to maintain and improve our gross margins and realize our
bookings, the seasonality of the markets we serve, the financial
performance of our subsidiaries and Emerging Technology Division, and
other risks described in our filings with the Securities and Exchange
Commission. We assume no responsibility to update any such
forward-looking statements.
Cypress, the Cypress logo, PSoC, TrueTouch, EZ-USB, and CapSense are
registered trademarks, and PSoC Components, PSoC Creator, PSoC Designer,
FX3, and S8 are trademarks of Cypress Semiconductor Corp. All other
trademarks or registered trademarks are the property of their respective
owners.
|
CYPRESS SEMICONDUCTOR CORPORATION
|
CONDENSED CONSOLIDATED BALANCE SHEETS
|
(In thousands)
|
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
June 30,
|
|
December 30,
|
|
|
2013
|
|
2012
|
|
|
|
|
|
|
|
|
|
ASSETS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash, cash equivalents and short-term investments
|
|
$
|
101,987
|
|
|
$
|
117,210
|
|
Accounts receivable, net
|
|
|
114,792
|
|
|
|
82,920
|
|
Inventories, net (a)
|
|
|
98,580
|
|
|
|
127,596
|
|
Property, plant and equipment, net
|
|
|
262,586
|
|
|
|
274,427
|
|
Goodwill and other intangible assets, net
|
|
|
110,812
|
|
|
|
113,410
|
|
Other assets
|
|
|
120,866
|
|
|
|
116,066
|
|
Total assets
|
|
$
|
809,623
|
|
|
$
|
831,629
|
|
|
|
|
|
|
|
|
|
|
LIABILITIES AND EQUITY
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accounts payable
|
|
$
|
58,468
|
|
|
$
|
58,704
|
|
Deferred margin on sales to distributors
|
|
|
158,409
|
|
|
|
131,192
|
|
Income tax liabilities
|
|
|
31,433
|
|
|
|
47,454
|
|
Other liabilities
|
|
|
169,197
|
|
|
|
185,418
|
|
Long-term revolving credit facility
|
|
|
227,000
|
|
|
|
232,000
|
|
Total liabilities
|
|
|
644,507
|
|
|
|
654,768
|
|
Total Cypress stockholders' equity
|
|
|
170,234
|
|
|
|
180,900
|
|
Noncontrolling interest
|
|
|
(5,118
|
)
|
|
|
(4,039
|
)
|
Total equity
|
|
|
165,116
|
|
|
|
176,861
|
|
Total liabilities and equity
|
|
$
|
809,623
|
|
|
$
|
831,629
|
|
|
(a)
|
|
Net inventories include $3.6 million and $2.8 million of capitalized
inventories related to stock compensation expense, as of June 30,
2013 and December 30, 2012, respectively.
|
|
CYPRESS SEMICONDUCTOR CORPORATION
|
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
|
ON A GAAP BASIS
|
(In thousands, except per-share data)
|
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
|
|
|
June 30,
|
|
March 31,
|
|
July 1,
|
|
|
2013
|
|
2013
|
|
2012
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenues
|
|
$
|
193,466
|
|
|
$
|
172,728
|
|
|
$
|
201,300
|
Cost of revenues
|
|
|
102,041
|
|
|
|
93,682
|
|
|
|
94,531
|
Gross margin
|
|
|
91,425
|
|
|
|
79,046
|
|
|
|
106,769
|
Operating expenses:
|
|
|
|
|
|
|
|
|
|
|
|
Research and development
|
|
|
48,804
|
|
|
|
49,330
|
|
|
|
47,946
|
Selling, general and administrative
|
|
|
48,073
|
|
|
|
45,442
|
|
|
|
51,955
|
Amortization of acquisition-related intangibles
|
|
|
1,987
|
|
|
|
2,009
|
|
|
|
731
|
Restructuring charges
|
|
|
693
|
|
|
|
11,440
|
|
|
|
989
|
|
|
|
|
|
|
|
|
|
|
|
|
Total operating expenses, net
|
|
|
99,557
|
|
|
|
108,221
|
|
|
|
101,621
|
Operating income (loss)
|
|
|
(8,132
|
)
|
|
|
(29,175
|
)
|
|
|
5,148
|
Interest and other income, net
|
|
|
2,119
|
|
|
|
483
|
|
|
|
1
|
Income (loss) before income taxes
|
|
|
(6,013
|
)
|
|
|
(28,692
|
)
|
|
|
5,149
|
Income tax provision (benefit)
|
|
|
(9,343
|
)
|
|
|
146
|
|
|
|
517
|
Income (loss), net of taxes
|
|
|
3,330
|
|
|
|
(28,838
|
)
|
|
|
4,632
|
Adjust for net loss attributable to noncontrolling interest
|
|
|
436
|
|
|
|
643
|
|
|
|
345
|
Net Income (loss) attributable to Cypress
|
|
$
|
3,766
|
|
|
$
|
(28,195
|
)
|
|
$
|
4,977
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Income (loss) per share attributable to Cypress:
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
$
|
0.03
|
|
|
$
|
(0.19
|
)
|
|
$
|
0.03
|
Diluted
|
|
$
|
0.02
|
|
|
$
|
(0.19
|
)
|
|
$
|
0.03
|
Cash dividend per share
|
|
$
|
0.11
|
|
|
$
|
0.11
|
|
|
$
|
0.11
|
Shares used in net income (loss) per share calculation:
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
|
147,287
|
|
|
|
145,689
|
|
|
|
151,765
|
Diluted
|
|
|
156,262
|
|
|
|
145,689
|
|
|
|
164,605
|
|
|
|
|
|
|
|
|
|
|
|
|
|
CYPRESS SEMICONDUCTOR CORPORATION
|
RECONCILIATION OF GAAP FINANCIAL MEASURES TO NON-GAAP FINANCIAL
MEASURES (a)
|
(In thousands, except per-share data)
|
(Unaudited)
|
|
|
|
|
|
Three Months Ended
|
|
|
June 30,
|
|
March 31,
|
|
July 1,
|
|
|
2013
|
|
2013
|
|
2012
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GAAP gross margin
|
|
$
|
91,425
|
|
|
$
|
79,046
|
|
|
$
|
106,769
|
|
Stock-based compensation expense
|
|
|
3,279
|
|
|
|
3,618
|
|
|
|
7,759
|
|
Acquisition-related expense
|
|
|
1,321
|
|
|
|
122
|
|
|
|
-
|
|
Changes in value of deferred compensation plan
|
|
|
31
|
|
|
|
422
|
|
|
|
(40
|
)
|
Impairment of assets and other
|
|
|
6,681
|
|
|
|
4,307
|
|
|
|
314
|
|
Restructuring charges
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
Non-GAAP gross margin
|
|
$
|
102,737
|
|
|
$
|
87,515
|
|
|
$
|
114,802
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GAAP research and development expenses
|
|
$
|
48,804
|
|
|
$
|
49,330
|
|
|
$
|
47,946
|
|
Stock-based compensation expense
|
|
|
(6,913
|
)
|
|
|
(4,967
|
)
|
|
|
(5,480
|
)
|
Acquisition-related expense
|
|
|
(26
|
)
|
|
|
(207
|
)
|
|
|
-
|
|
Changes in value of deferred compensation plan
|
|
|
(99
|
)
|
|
|
(815
|
)
|
|
|
89
|
|
Impairment of assets and other
|
|
|
-
|
|
|
|
(1,394
|
)
|
|
|
-
|
|
Non-GAAP research and development expenses
|
|
$
|
41,766
|
|
|
$
|
41,947
|
|
|
$
|
42,555
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GAAP selling, general and administrative expenses
|
|
$
|
48,073
|
|
|
$
|
45,442
|
|
|
$
|
51,955
|
|
Stock-based compensation expense
|
|
|
(10,203
|
)
|
|
|
(3,852
|
)
|
|
|
(8,991
|
)
|
Acquisition-related expense
|
|
|
(98
|
)
|
|
|
(556
|
)
|
|
|
(2,003
|
)
|
Changes in value of deferred compensation plan
|
|
|
(145
|
)
|
|
|
(1,861
|
)
|
|
|
183
|
|
Impairment of assets and other
|
|
|
(160
|
)
|
|
|
(177
|
)
|
|
|
-
|
|
Non-GAAP selling, general and administrative expenses
|
|
$
|
37,467
|
|
|
$
|
38,996
|
|
|
$
|
41,144
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GAAP operating income (loss)
|
|
$
|
(8,132
|
)
|
|
$
|
(29,175
|
)
|
|
$
|
5,148
|
|
Stock-based compensation expense
|
|
|
20,395
|
|
|
|
12,437
|
|
|
|
22,230
|
|
Acquisition-related expense
|
|
|
3,432
|
|
|
|
2,894
|
|
|
|
2,734
|
|
Changes in value of deferred compensation plan
|
|
|
275
|
|
|
|
3,098
|
|
|
|
(311
|
)
|
Impairment of assets and other
|
|
|
6,841
|
|
|
|
5,878
|
|
|
|
315
|
|
Restructuring charges
|
|
|
693
|
|
|
|
11,440
|
|
|
|
989
|
|
Non-GAAP operating income
|
|
$
|
23,504
|
|
|
$
|
6,572
|
|
|
$
|
31,105
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GAAP net income (loss) attributable to Cypress
|
|
$
|
3,766
|
|
|
$
|
(28,195
|
)
|
|
$
|
4,977
|
|
Stock-based compensation expense
|
|
|
20,395
|
|
|
|
12,437
|
|
|
|
22,230
|
|
Acquisition-related expense
|
|
|
3,432
|
|
|
|
2,894
|
|
|
|
2,734
|
|
Changes in value of deferred compensation plan
|
|
|
(21
|
)
|
|
|
674
|
|
|
|
530
|
|
Impairment of assets and other
|
|
|
5,763
|
|
|
|
5,525
|
|
|
|
315
|
|
Restructuring charges
|
|
|
693
|
|
|
|
11,440
|
|
|
|
989
|
|
Tax and tax-related items
|
|
|
(12,393
|
)
|
|
|
(196
|
)
|
|
|
(1,477
|
)
|
Non-GAAP net income attributable to Cypress
|
|
$
|
21,635
|
|
|
$
|
4,579
|
|
|
$
|
30,298
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GAAP net income (loss) per share attributable to Cypress - diluted
|
|
$
|
0.02
|
|
|
$
|
(0.19
|
)
|
|
$
|
0.03
|
|
Stock-based compensation expense
|
|
|
0.13
|
|
|
|
0.08
|
|
|
|
0.14
|
|
Acquisition-related expense
|
|
|
0.02
|
|
|
|
0.02
|
|
|
|
0.02
|
|
Changes in value of deferred compensation plan
|
|
|
-
|
|
|
|
0.01
|
|
|
|
-
|
|
Impairment of assets and other
|
|
|
0.04
|
|
|
|
0.04
|
|
|
|
-
|
|
Restructuring charges
|
|
|
0.01
|
|
|
|
0.07
|
|
|
|
0.01
|
|
Tax and tax-related items
|
|
|
(0.08
|
)
|
|
|
-
|
|
|
|
(0.01
|
)
|
Non-GAAP share count adjustment
|
|
|
-
|
|
|
|
-
|
|
|
|
(0.01
|
)
|
Non-GAAP net income per share attributable to Cypress - diluted
|
|
$
|
0.14
|
|
|
$
|
0.03
|
|
|
$
|
0.18
|
|
|
(a)
|
|
Refer to the accompanying "Notes to Non-GAAP Financial Measures" for
a detailed discussion of management's use of non-GAAP financial
measures.
|
|
CYPRESS SEMICONDUCTOR CORPORATION
|
SUPPLEMENTAL FINANCIAL DATA
|
(In thousands)
|
(Unaudited)
|
|
|
|
|
|
|
|
|
Three Months Ended
|
|
|
Six Months Ended
|
|
|
June 30,
|
|
March 31,
|
|
July 1,
|
|
|
June 30,
|
|
July 1,
|
|
|
2013
|
|
2013
|
|
2012
|
|
|
2013
|
|
2012
|
Selected Cash Flow Data (Preliminary):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by operating activities
|
|
$
|
30,355
|
|
|
$
|
8,265
|
|
|
$
|
43,303
|
|
|
|
$
|
38,620
|
|
|
$
|
59,630
|
|
Net cash provided by (used in) investing activities
|
|
$
|
3,545
|
|
|
$
|
(895
|
)
|
|
$
|
(49,477
|
)
|
|
|
$
|
2,650
|
|
|
$
|
(47,984
|
)
|
Net cash provided by (used in) financing activities
|
|
$
|
(20,502
|
)
|
|
$
|
(13,354
|
)
|
|
$
|
63,152
|
|
|
|
$
|
(33,856
|
)
|
|
$
|
6,899
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other Supplemental Data (Preliminary):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Capital expenditures
|
|
$
|
7,771
|
|
|
$
|
9,298
|
|
|
$
|
9,741
|
|
|
|
$
|
17,069
|
|
|
$
|
19,716
|
|
Depreciation
|
|
$
|
10,036
|
|
|
$
|
10,355
|
|
|
$
|
11,668
|
|
|
|
$
|
20,391
|
|
|
$
|
22,350
|
|
Payment of dividend
|
|
$
|
16,138
|
|
|
$
|
15,845
|
|
|
$
|
16,716
|
|
|
|
$
|
31,983
|
|
|
$
|
30,510
|
|
Dividend paid per share
|
|
$
|
0.11
|
|
|
$
|
0.11
|
|
|
$
|
0.11
|
|
|
|
$
|
0.22
|
|
|
$
|
0.22
|
|
Dividend yield per share (a)
|
|
|
4.1
|
%
|
|
|
4.0
|
%
|
|
|
3.3
|
%
|
|
|
|
4.1
|
%
|
|
|
3.3
|
%
|
|
(a)
|
|
Dividend yield per share is calculated based on annualized dividend
paid per share divided by the common stock share price at the end of
the period.
|
|
CYPRESS SEMICONDUCTOR CORPORATION
|
CONSOLIDATED DILUTED EPS CALCULATION
|
(In thousands, except per-share data)
|
(Unaudited)
|
|
|
|
|
|
Three Months Ended
|
|
|
June 30,
|
|
March 31,
|
|
July 1,
|
|
|
2013
|
|
2013
|
|
2012
|
|
|
GAAP
|
|
Non-GAAP
|
|
GAAP
|
|
Non-GAAP
|
|
GAAP
|
|
Non-GAAP
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) attributable to Cypress
|
|
$
|
3,766
|
|
$
|
21,635
|
|
$
|
(28,195
|
)
|
|
$
|
4,579
|
|
$
|
4,977
|
|
$
|
30,298
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted-average common shares outstanding (basic)
|
|
|
147,287
|
|
|
147,287
|
|
|
145,689
|
|
|
|
145,689
|
|
|
151,765
|
|
|
151,765
|
Effect of dilutive securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock options, unvested restricted stock and other
|
|
|
8,975
|
|
|
12,500
|
|
|
-
|
|
|
|
12,569
|
|
|
12,840
|
|
|
16,075
|
Weighted-average common shares outstanding for diluted computation
|
|
|
156,262
|
|
|
159,787
|
|
|
145,689
|
|
|
|
158,258
|
|
|
164,605
|
|
|
167,840
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) per share attributable to Cypress - basic
|
|
$
|
0.03
|
|
$
|
0.15
|
|
$
|
(0.19
|
)
|
|
$
|
0.03
|
|
$
|
0.03
|
|
$
|
0.20
|
Net income (loss) per share attributable to Cypress - diluted
|
|
$
|
0.02
|
|
$
|
0.14
|
|
$
|
(0.19
|
)
|
|
$
|
0.03
|
|
$
|
0.03
|
|
$
|
0.18
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
June 30,
|
|
March 31,
|
|
July 1,
|
|
|
2013
|
|
2013
|
|
2012
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Average stock price for the period ended
|
|
$10.72
|
|
$10.50
|
|
$13.69
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock outstanding at period end (in thousands)
|
|
147,972
|
|
146,866
|
|
151,470
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Notes to Non-GAAP Financial Measures
To supplement its consolidated financial results presented in accordance
with GAAP, Cypress uses non-GAAP financial measures which are adjusted
from the most directly comparable GAAP financial measures to exclude
certain items, as described in details below. Management believes that
these non-GAAP financial measures reflect an additional and useful way
of viewing aspects of Cypress’s operations that, when viewed in
conjunction with Cypress’s GAAP results, provide a more comprehensive
understanding of the various factors and trends affecting Cypress’s
business and operations. Non-GAAP financial measures used by Cypress
include:
•
|
|
Gross margin;
|
•
|
|
Research and development expenses;
|
•
|
|
Selling, general and administrative expenses;
|
•
|
|
Operating income (loss);
|
•
|
|
Net income (loss); and
|
•
|
|
Diluted net income (loss) per share.
|
|
|
|
Cypress uses each of these non-GAAP financial measures for internal
managerial purposes, when providing its financial results and business
outlook to the public, and to facilitate period-to-period comparisons.
Management believes that these non-GAAP measures provide meaningful
supplemental information regarding Cypress’s operational and financial
performance of current and historical results. Management uses these
non-GAAP measures for strategic and business decision making, internal
budgeting, forecasting and resource allocation processes. In addition,
these non-GAAP financial measures facilitate management’s internal
comparisons to Cypress’s historical operating results and comparisons to
competitors’ operating results.
Cypress believes that providing these non-GAAP financial measures, in
addition to the GAAP financial results, are useful to investors because
they allow investors to see Cypress’s results “through the eyes” of
management as these non-GAAP financial measures reflect Cypress’s
internal measurement processes. Management believes that these non-GAAP
financial measures enable investors to better assess changes in each key
element of Cypress’s operating results across different reporting
periods on a consistent basis. Thus, management believes that each of
these non-GAAP financial measures provides investors with another method
for assessing Cypress’s operating results in a manner that is focused on
the performance of its ongoing operations.
There are limitations in using non-GAAP financial measures because they
are not prepared in accordance with GAAP and may be different from
non-GAAP financial measures used by other companies. In addition,
non-GAAP financial measures may be limited in value because they exclude
certain items that may have a material impact upon Cypress’s reported
financial results. Management compensates for these limitations by
providing investors with reconciliations of the non-GAAP financial
measures to the most directly comparable GAAP financial measures. The
presentation of non-GAAP financial information is not meant to be
considered in isolation or as a substitute for the most directly
comparable GAAP financial measures. The non-GAAP financial measures
supplement, and should be viewed in conjunction with, GAAP financial
measures. Investors should review the reconciliations of the non-GAAP
financial measures to their most directly comparable GAAP financial
measures as provided in the accompanying press release.
As presented in the “Reconciliation of GAAP Financial Measures to
Non-GAAP Financial Measures” tables in the accompanying press release,
each of the non-GAAP financial measures excludes one or more of the
following items:
•
|
|
Stock-based compensation expense.
|
|
|
Stock-based compensation expense relates primarily to the equity
awards such as stock options and restricted stock. Stock-based
compensation is a non-cash expense that varies in amount from period
to period and is dependent on market forces that are often beyond
Cypress’s control. As a result, management excludes this item from
Cypress’s internal operating forecasts and models. Management
believes that non-GAAP measures adjusted for stock-based
compensation provide investors with a basis to measure Cypress’s
core performance against the performance of other companies without
the variability created by stock-based compensation as a result of
the variety of equity awards used by companies and the varying
methodologies and subjective assumptions used in determining such
non-cash expense.
|
•
|
|
Changes in value of Cypress’s key employee deferred compensation
plan.
|
|
|
Cypress sponsors a voluntary deferred compensation plan which
provides certain key employees with the option to defer the receipt
of compensation in order to accumulate funds for retirement. The
amounts are held in a trust and Cypress does not make contributions
to the deferred compensation plan or guarantee returns on the
investment. Changes in the value of the investments under the plan
are excluded from the non-GAAP measures. Management believes that
such non-cash item is not related to the ongoing core business and
operating performance of Cypress, as the investment contributions
are made by the employees themselves.
|
•
|
|
Restructuring charges.
|
|
|
Restructuring charges primarily relate to activities engaged by
management to make changes related to its infrastructure in an
effort to reduce costs. Restructuring charges are excluded from
non-GAAP financial measures because they are not considered core
operating activities and such costs have not historically occurred
in each year. Although Cypress has engaged in various restructuring
activities in the past, each has been a discrete event based on a
unique set of business objectives. As such, management believes that
it is appropriate to exclude restructuring charges from Cypress’s
non-GAAP financial measures as it enhances the ability of investors
to compare Cypress’s period-over-period operating results from
continuing operations.
|
•
|
|
Acquisition-related expense.
|
|
|
Acquisition-related expense primarily includes: (1) amortization of
intangibles, which include acquired intangibles such as purchased
technology, patents and trademarks, (2) costs such as advisory,
legal, accounting and other professional or consulting fees related
to acquisitions, (3) severance expense incurred in connection with
acquisition-related headcount reduction efforts, and (4) earn-out
compensation expense, which include compensation resulting from the
achievement of milestones established in accordance with the terms
of the acquisitions. In most cases, these acquisition-related
charges are not factored into management’s evaluation of potential
acquisitions or Cypress’s performance after completion of
acquisitions, because they are not related to Cypress’s core
operating performance. Adjustments of these items provide investors
with a basis to compare Cypress against the performance of other
companies without the variability caused by purchase accounting.
|
•
|
|
Impairment of assets.
|
|
|
Cypress wrote down the book value of certain assets to their
estimated fair value as management determined these assets will be
donated, sold or will have no future benefit. Cypress excludes these
items because the expense is not reflective of its ongoing operating
results. Excluding this data allows investors to better compare
Cypress’s period-over-period performance without such expense.
|
•
|
|
Taxes, tax effects and foreign currency gain/loss.
|
|
|
Cypress adjusts for the income tax effect that resulted from the
non-GAAP adjustments as described above. Additionally, Cypress also
excludes the impact of items that are related to historical
activities in nature and not reflective of the ongoing operating
results of Cypress, which can include completion of examinations by
our U.S. or foreign taxing authorities, lapse of statutes of
limitations and the resolution of agreements with domestic and
various foreign tax authorities. This also includes foreign currency
gain or loss effects on the activities mentioned above.
|
Copyright Business Wire 2013